Concentration-dependent effects of transforming growth factor β1 on corneal wound healing

Molecular Vision

Volumn 17, Issue , 2011, Pages 2835-2846

  Wang, Lingyan ^a   Ko, Chun Ying ^a   Meyers, Erin E ^a   Pedroja, Benjamin S ^a   Pelaez, Nadia ^a   Bernstein, Audrey M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; IMMUNOGLOBULIN G; MITOGEN ACTIVATED PROTEIN KINASE P38; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL NUCLEUS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORNEA; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME LOCALIZATION; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; KERATOMILEUSIS; MYOFIBROBLAST; OCULAR FIBROSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; WOUND CLOSURE; WOUND HEALING;

ACTINS; ANTIBODIES, BLOCKING; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CORNEA; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 83055170915     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Barbosa FL, Chaurasia SS, Cutler A, Asosingh K, Kaur H, de Medeiros FW, Agrawal V, Wilson SE. Corneal myofibroblast generation from bone marrow-derived cells. Exp Eye Res 2010; 91:92-6. [PMID: 20417632]
2. Kuo IC. Corneal wound healing. Curr Opin Ophthalmol 2004; 15:311-5. [PMID: 15232470]
3. Hassell JR, Birk DE. The molecular basis of corneal transparency. Exp Eye Res 2010; 91:326-35. [PMID: 20599432]
4. Dawson DG, Kramer TR, Grossniklaus HE, Waring GO 3rd, Edelhauser HF. Histologic, ultrastructural, and immunofluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds. Arch Ophthalmol 2005; 123:741-56. [PMID: 15955975]
5. Dawson DG, Schmack I, Holley GP, Waring GO 3rd, Grossniklaus HE, Edelhauser HF. Interface fluid syndrome in human eye bank corneas after LASIK: causes and pathogenesis. Ophthalmology 2007; 114:1848-59. [PMID: 17908592]
6. Erie JC, Patel SV, McLaren JW, Hodge DO, Bourne WM. Corneal keratocyte deficits after photorefractive keratectomy and laser in situ keratomileusis. Am J Ophthalmol 2006; 141:799-809. [PMID: 16545332]
7. Schmack I, Dawson DG, McCarey BE, Waring GO 3rd, Grossniklaus HE, Edelhauser HF. Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg 2005; 21:433-45. [PMID: 16209440]
8. Meghpara B, Nakamura H, Macsai M, Sugar J, Hidayat A, Yue BY, Edward DP. Keratectasia after laser in situ keratomileusis: a histopathologic and immunohistochemical study. Arch Ophthalmol 2008; 126:1655-63. [PMID: 19064844]
9. Møller-Pedersen T, Cavanagh HD, Petroll WM, Jester JV. Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr Eye Res 1998; 17:736-47. [PMID: 9678420]
10. Carrington LM, Albon J, Anderson I, Kamma C, Boulton M. Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors. Invest Ophthalmol Vis Sci 2006; 47:1886-94. [PMID: 16638995]
11. Sumioka T, Ikeda K, Okada Y, Yamanaka O, Kitano A, Saika S. Inhibitory effect of blocking TGF-beta/Smad signal on injury-induced fibrosis of corneal endothelium. Mol Vis 2008; 14:2272-81. [PMID: 19081766]
12. Saika S, Okada Y, Miyamoto T, Yamanaka O, Ohnishi Y, Ooshima A, Liu CY, Weng D, Kao WW. Role of p38 MAP kinase in regulation of cell migration and proliferation in healing corneal epithelium. Invest Ophthalmol Vis Sci 2004; 45:100-9. [PMID: 14691160]
13. Saika S. TGF-beta signal transduction in corneal wound healing as a therapeutic target. Cornea 2004; 23:S25-30. [PMID: 15448476]
14. Bernstein AM, Greenberg RS, Taliana L, Masur SK. Urokinase anchors uPAR to the actin cytoskeleton. Invest Ophthalmol Vis Sci 2004; 45:2967-77. [PMID: 15326109]
15. Song QH, Singh RP, Richardson TP, Nugent MA, Trinkaus-Randall V. Transforming growth factor-beta1 expression in cultured corneal fibroblasts in response to injury. J Cell Biochem 2000; 77:186-99. [PMID: 10723086]
16. Hinz B, Gabbiani G. Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives. F1000 Biol Rep 2010; 2:78. [PMID: 21170369]
17. Thomas GJ, Hart IR, Speight PM, Marshall JF. Binding of TGFbeta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells. Br J Cancer 2002; 87:859-67. [PMID: 12373600]
18. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB. An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 1994; 216:276-84. [PMID: 8179182]
19. Pedroja BS, Kang LE, Imas AO, Carmeliet P, Bernstein AM. Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling. J Biol Chem 2009; 284:20708-17. [PMID: 19487690]
20. Stramer BM, Austin JS, Roberts AB, Fini ME. Selective reduction of fibrotic markers in repairing corneas of mice deficient in Smad3. J Cell Physiol 2005; 203:226-32. [PMID: 15521071]
21. Kamaraju AK, Roberts AB. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 2005; 280:1024-36. [PMID: 15520018]
22. Zhang GY, Li X, Yi CG, Pan H, He GD, Yu Q, Jiang LF, Xu WH, Li ZJ, Ding J, Lin DS, Gao WY. Angiotensin II activates connective tissue growth factor and induces extracellular matrix changes involving Smad/activation and p38 mitogenactivated protein kinase signalling pathways in human dermal fibroblasts. Exp Dermatol 2009; 18:947-53. [PMID: 19397700]
23. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 2002; 62:65-74. [PMID: 12065756]
24. Mi S, Dooley EP, Albon J, Boulton ME, Meek KM, Kamma-Lorger CS. Adhesion of laser in situ keratomileusis-like flaps in the cornea: Effects of crosslinking, stromal fibroblasts, and cytokine treatment. J Cataract Refract Surg 2011; 37:166-72. [PMID: 21183111]
25. Navarro A, Rezaiekhaligh M, Keightley JA, Mabry SM, Perez RE, Ekekezie II. Higher TRIP-1 level explains diminished collagen contraction ability of fetal versus adult fibroblasts. Am J Physiol Lung Cell Mol Physiol 2009; 296:L928-35. [PMID: 19329541]
26. Perez RE, Navarro A, Rezaiekhaligh MH, Mabry SM, Ekekezie II. TRIP-1 Regulates TGF-{beta}1 Induced Epithelial Mesenchymal Transition of the Human Lung Epithelial Cell Line A549. Am J Physiol Lung Cell Mol Physiol 2011; 300:L799-807. [PMID: 21378021]
27. Terai K, Call MK, Liu H, Saika S, Liu CY, Hayashi Y, Chikama T, Zhang J, Terai N, Kao CW, Kao WW. Crosstalk between TGF-{beta} and MAPK Signaling during Corneal Wound Healing. Invest Ophthalmol Vis Sci 2011; 52:8208-15. [PMID: 21917935]